Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tencent Music

18.69
-0.1450-0.77%
Volume:1.93M
Turnover:36.03M
Market Cap:28.95B
PE:22.29
High:18.81
Open:18.49
Low:18.35
Close:18.84
Loading ...

China ADRs & ETFs Drop. PDD Down 5%; YINN Slides 4%; NIO Sinks 3%; Alibaba Falls 2%

Tiger Newspress
·
05 Feb

24H|China A50 Index Futures Fall 2%. YINN Drops 7%; XPeng, PDD Down 5%

Tiger Newspress
·
05 Feb

Chinese ADRs Extend Gains; XPeng up 9%, PDD up 8%, Li Auto up 7%, Alibaba up 5%

Tiger Newspress
·
05 Feb

BUZZ-China ADRs recover despite tit-for-tat tariffs

Reuters
·
05 Feb

IO Biotech Announces Publication of Preclinical Data Investigating Immune-Modulatory Effects of IO112, an Arginase 1-Targeting Therapeutic Cancer Vaccine Candidate

GlobeNewswire
·
04 Feb

Purple Biotech Announces Research Collaboration with the Icahn School of Medicine at Mount Sinai for CAPTN-3 Tri-Specific Antibody Platform

GlobeNewswire
·
03 Feb

24H|U.S. Stocks Plunge As U.S. Trade War Erupts

Tiger Newspress
·
03 Feb

Chinese ADRs & ETFs Extend Rally. iQiyi up 10%; YINN up 7.7%; Alibaba, NIO up 5%

Tiger Newspress
·
31 Jan

Press Release: Eterna Therapeutics Announces Expansion of Scientific Advisory Board

Dow Jones
·
28 Jan

China A50 Index Futures Jump 1%. Chinese ADRs & ETFs Rally Premarket With YINN Jumping over 3%

Tiger Newspress
·
27 Jan

Stock Track | Tencent Music Soars 5.07% on Easing US-China Trade Tensions

Stock Track
·
25 Jan

Chinese ADRs & ETFs Jump. YINN up 4%; JD.com up 3%; XPeng, PDD Holdings, iQiyi up over 2%.

Tiger Newspress
·
24 Jan

Trump Gives His Biggest Tariffs Hint Yet. What It Means for Markets

Dow Jones
·
24 Jan

24H|Chinese ADRs Buoyed by Trump's China Comments

Tiger Newspress
·
24 Jan

Chinese ADRs & ETFs Drop. XPeng Sinks 3%; KE Holdings, MINISO Group, NIO, Fall over 2%; YINN, Alibaba, PDD Fall 1%

Tiger Newspress
·
23 Jan

Analysts Offer Insights on Communication Services Companies: Tencent Music Entertainment Group (TME) and Electronic Arts (EA)

TIPRANKS
·
23 Jan

24H|Chinese ADRs Decline as Traders Digest China's Stimulus Measures

Tiger Newspress
·
23 Jan

China's CSRC Chairman Wu Qing: Public Funds to Increase A-Share Holdings by at Least 10% Annually over Next 3 Years

Reuters
·
23 Jan

Xilio Therapeutics Announces Initial Phase 2 Data for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer

GlobeNewswire
·
22 Jan

Sonnet BioTherapeutics Expands Phase 1 SB101 Trial to Evaluate Combination of SON-1010 with Trabectedin in Certain Sarcomas

GlobeNewswire
·
21 Jan